n-(2-hydroxypropyl)methacrylamide has been researched along with thapsigargin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chandran, SS; Denmeade, SR; Ghandehari, H; Nan, A; Rosen, DM | 1 |
1 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and thapsigargin
Article | Year |
---|---|
A prostate-specific antigen activated N-(2-hydroxypropyl) methacrylamide copolymer prodrug as dual-targeted therapy for prostate cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Coumarins; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Hydrolysis; Male; Mice; Mice, Nude; Micelles; Organ Specificity; Polymers; Polymethacrylic Acids; Prodrugs; Prostate-Specific Antigen; Prostatic Neoplasms; Thapsigargin | 2007 |